Treatment choices based on Onco type Dx in the breast oncology care setting

Journal of Cancer Epidemiology

Volumn , Issue , 2012, Pages

  Malo, Teri L ^a   Lipkus, Isaac ^b   Wilson, Tobi ^c   Han, Hyo S ^a,d   Acs, Geza ^a,d   Vadaparampil, Susan T ^a,d  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER PATIENT; CANCER RECURRENCE; CANCER TEST; DRUG UPTAKE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; ONCOTYPEDX TEST; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 84866248591     PISSN: 16878558     EISSN: 16878566     Source Type: Journal    
DOI: 10.1155/2012/941495     Document Type: Article

References (22)

1. Siegel R., Naishadham D., Jemal A., Cancer statistics, 2012. CA Cancer Journal for Clinicians 2012 62 1 10 29 2-s2.0-84855792427 10.3322/caac.20138
2. Yang M., Rajan S., Issa A. M., Cost effectiveness of gene expression profiling for early stage breast cancer: a decision-analytic model. Cancer. In press 2-s2.0-84857220303 10.1002/cncr.27443
3. Ishibe N., Schully S., Freedman A., Ramsey S. D., Use of Oncotype DX in women with node-positive breast cancer. PLoS Currents 2011 3 article RRN1249
4. Ellsworth R. E., Decewicz D. J., Shriver C. D., Ellsworth D. L., Breast cancer in the personal genomics era. Current Genomics 2010 11 3 146 161 2-s2.0-77952507615 10.2174/138920210791110951
5. Wideroff L., Phillips K. A., Randhawa G., Ambs A., Armstrong K., Bennett C. L., Brown M. L., Donaldson M. S., Follen M., Goldie S. J., Hiatt R. A., Khoury M. J., Lewis G., McLeod H. L., Piper M., Powell I., Schrag D., Schulman K. A., Scott J., A health services research agenda for cellular, molecular and genomic technologies in cancer care. Public Health Genomics 2009 12 4 233 244 2-s2.0-67449086758 10.1159/000203779
6. Harris L., Fritsche H., Mennel R., Norton L., Ravdin P., Taube S., Somerfield M. R., Hayes D. F., Bast R. C., American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer. Journal of Clinical Oncology 2007 25 33 5287 5312 2-s2.0-36849069347 10.1200/JCO.2007.14.2364 (Pubitemid 350232263)
7. Anderson W. F., Chatterjee N., Ershler W. B., Brawley O. W., Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. Breast Cancer Research and Treatment 2002 76 1 27 36 2-s2.0-0036838070 10.1023/A:1020299707510 (Pubitemid 35178626)
8. Ademuyiwa F. O., Miller A., O'Connor T., Edge S. B., Thorat M. A., Sledge G. W., Levine E., Badve S., The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohort. Breast Cancer Research and Treatment 2011 126 3 797 802 2-s2.0-79958755732 10.1007/s10549-010-1329-6
9. Henry L. R., Stojadinovic A., Swain S. M., Prindiville S., Cordes R., Soballe P. W., The influence of a gene expression profile on breast cancer decisions. Journal of Surgical Oncology 2009 99 6 319 323 2-s2.0-65449138790 10.1002/jso.21244
10. Asad J., Jacobson A. F., Estabrook A., Smith S. R., Boolbol S. K., Feldman S. M., Osborne M. P., Boachie-Adjei K., Twardzik W., Tartter P. I., Does oncotype DX recurrence score affect the management of patients with early-stage breast cancer? American Journal of Surgery 2008 196 4 527 529 2-s2.0-52049089470 10.1016/j.amjsurg.2008.06.021
11. Oratz R., Paul D., Cohn A. L., Sedlacek S. M., Impact of a commercial reference laboratory test recurrence score on decision making in early-stage breast cancer. Journal of Oncology Practice 2007 3 4 182 186 2-s2.0-42649098952 10.1200/JOP.0742001 (Pubitemid 351593669)
12. Lo S. S., Mumby P. B., Norton J., Rychlik K., Smerage J., Kash J., Chew H. K., Gaynor E. R., Hayes D. F., Epstein A., Albain K. S., Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection. Journal of Clinical Oncology 2010 28 10 1671 1676 2-s2.0-77950494285 10.1200/JCO.2008.20. 2119
13. Paik S., Shak S., Tang G., Kim C., Baker J., Cronin M., Baehner F. L., Walker M. G., Watson D., Park T., Hiller W., Fisher E. R., Wickerham D. L., Bryant J., Wolmark N., A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. New England Journal of Medicine 2004 351 27 2817 2826 2-s2.0-19944422061 10.1056/NEJMoa041588 (Pubitemid 40051905)
14. Paik S., Shak S., Tang G., Expression of the 21 genes in the Recurrence Score assay and prediction of clinical benefits in the tamoxifen NSABP study B-14 and chemotherapy in the NSABP study B-20. Breast Cancer Research and Treatment 2004 88 supplement 1 S15 S24
15. Liang H., Burfsky A., Lembersky B., Rastogi P., Vogel V., A retrospective analysis of the impact of OncotypeDX low recurrence score results on treatment decisions in a single academic breast cancer center. Breast Cancer Research and Treatment 2007 106 supplement S105, abstract
16. O'Neill S. C., Brewer N. T., Lillie S. E., Morrill E. F., Dees E. C., Carey L. A., Rimer B. K., Women's interest in gene expression analysis for breast cancer recurrence risk. Journal of Clinical Oncology 2007 25 29 4628 4634 2-s2.0-35648995985 10.1200/JCO.2006.09.6255 (Pubitemid 350035323)
17. Lipkus I. M., Vadaparampil S. T., Jacobsen P. B., Miree C. A., Knowledge about genomic recurrence risk testing among breast cancer survivors. Journal of Cancer Education 2011 26 4 664 669 2-s2.0-79959264018 10.1007/s13187-011-0248-5
18. Tzeng J. P., Mayer D., Richman A. R., Lipkus I., Han P. K., Valle C. G., Carey L. A., Brewer N. T., Women's experiences with genomic testing for breast cancer recurrence risk. Cancer 2010 116 8 1992 2000 2-s2.0-77951019146 10.1002/cncr.24990
19. Guth A. A., Fineberg S., Fei K., Franco R., Bickell N., Utilization of Oncotype DX to predict chemotherapy use in an inner-city population. Journal of Clinical Oncology 2011 29 abstract e11131
20. Mai P. L., Garceau A. O., Graubard B. I., Dunn M., McNeel T. S., Gonsalves L., Gail M. H., Greene M. H., Willis G. B., Wideroff L., Confirmation of family cancer history reported in a population-based survey. Journal of the National Cancer Institute 2011 103 10 788 797 2-s2.0-79957442482 10.1093/jnci/djr114
21. Qureshi N., Wilson B., Santaguida P., NIH state-of-the-science conference: family history and improving health. Evidence Report/Technology Assessment 2009 186, AHRQ Publication no. 09-E016 Rockville, Md, USA Agency for Healthcare Research and Quality. Prepared by the McMaster University Evidence-based Practice Center, under Contract No. 290-2007-10060-I
22. Hawfield A., Lovato J., Covington D., Kimmick G., Retrospective study of the effect of comorbidity on use of adjuvant chemotherapy in older women with breast cancer in a tertiary care setting. Critical Reviews in Oncology/Hematology 2006 59 3 250 255 2-s2.0-33747810443 10.1016/j.critrevonc. 2005.12.004 (Pubitemid 44279422)